SLC12A2 and schizophrenia: This has prompted researchers to look at the reversal potential of GABA and/or the expression of NKCC1, KCC2 cation-chloride co-transporters and their associated regulatory pathways in mouse models of schizophrenia and post-mortem human tissues.